z-logo
Premium
Chiral synthesis of (2 S ,3 S )‐2‐(2‐morpholin‐2‐yl‐2‐phenylmethoxy)phenol
Author(s) -
Prabhakaran Jaya,
Majo Vattoly J.,
Mann J. John,
Dileep Kumar J. S.
Publication year - 2004
Publication title -
chirality
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 77
eISSN - 1520-636X
pISSN - 0899-0042
DOI - 10.1002/chir.20004
Subject(s) - morpholine , chemistry , methanol , stereochemistry , yield (engineering) , phenol , epoxide , medicinal chemistry , organic chemistry , catalysis , materials science , metallurgy
Resolution of (2 RS ,3 RS )‐2‐[α‐(2‐methoxymethoxyphenoxy)phenylmethyl]morpholine, 11 , with (+) mandelic acid led to the formation of (+)‐(2 S ,3 S )‐2‐[α‐(2‐methoxymethoxyphenoxy)phenyl methyl] morpholine ( 11a ). Compound 11 was synthesized in seven steps from (2 RS ,3 RS )‐cinnamyl alcohol‐2,3‐epoxide ( 4 ), with an overall yield of 17%. Cleavage of the methoxymethyl group of the Fmoc derivative 12 with catalytic amounts of p ‐toluenesulfonic acid in methanol afforded (+)‐(2 S ,3 S )‐2‐(2‐morpholin‐2‐yl‐2‐phenylmethoxy)phenol 2 . The synthetic utility as well as the configuration of compound 2 has been demonstrated by converting ( S,S )‐2‐(2‐morpholin‐2‐yl‐2‐phenylmethoxy)phenol 2 to (2 S ,3 S )‐2‐[α‐(2‐ethoxyphenoxy)phenylmethyl]morpholine ( 1 ) and (2 S ,3 S )‐2‐(2‐methoxyphenoxy) benzyl)morpholine ( 16 ), two potential norepinephrine reuptake inhibitors under clinical evaluation. Chirality 16:168–173, 2004. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom